BML Capital Management, LLC Diversified Active

CIK: 0001616824 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 3, 2026

Total Value ($000): $115,689 (100.0% shares, 0.0% debt)

Holdings (16)

New Positions (5)

KMX CARMAX INC 5.2%

Value ($000) $5,989 Shares 155,000 Est. Cost $39.99 Unrealized 0.0%

CVNA CARVANA CO 1.7%

Value ($000) $2,016 Shares 150 Est. Cost — Unrealized —

OM OUTSET MED INC 1.7%

Value ($000) $2,015 Shares 543,180 Est. Cost $8.58 Unrealized 0.0%

PLRX PLIANT THERAPEUTICS INC 1.6%

Value ($000) $1,886 Shares 1,546,137 Est. Cost $1.50 Unrealized 0.0%

TSLA TESLA INC 0.2%

Value ($000) $205 Shares 1,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
KMX	CARMAX INC	155,000	$5,989	5.2%	$39.99	0.0%	COM	143130102
CVNA	CARVANA CO	150	$2,016	1.7%	—	—	PUT	146869102
OM	OUTSET MED INC	543,180	$2,015	1.7%	$8.58	0.0%	COM NEW	690145206
PLRX	PLIANT THERAPEUTICS INC	1,546,137	$1,886	1.6%	$1.50	0.0%	COM	729139105
TSLA	TESLA INC	1,000	$205	0.2%	—	—	PUT	88160R101

Increased Positions (2)

TGT TARGET CORP 3.2%

Value ($000) $3,666 (+308.7%) Shares 37,500 (+275.0%) Est. Cost $92.99 Unrealized -1.5%

WMT WALMART INC 0.4%

Value ($000) $492 (-5.1%) Shares 335 (+26.4%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TGT	TARGET CORP	37,500 (+275.0%)	$3,666 (+308.7%)	3.2%	$92.99	-1.5%	COM	87612E106
WMT	WALMART INC	335 (+26.4%)	$492 (-5.1%)	0.4%	—	—	PUT	931142103

Exited Positions (9)

— ADVERUM BIOTECHNOLOGIES INC 12.0%

Value ($000) $13,851 Shares 3,057,526 Est. Cost $7.99 Unrealized —

ALMS ALUMIS INC 4.2%

Value ($000) $4,830 Shares 1,210,415 Est. Cost $4.77 Unrealized +46.4%

— LAVA THERAPEUTICS NV 2.7%

Value ($000) $3,074 Shares 1,970,610 Est. Cost $1.27 Unrealized —

LONA ATHIRA PHARMA INC 1.2%

Value ($000) $1,337 Shares 323,066 Est. Cost $3.92 Unrealized +16.7%

ASTC ASTROTECH CORP 0.9%

Value ($000) $1,080 Shares 220,410 Est. Cost $11.26 Unrealized -66.0%

VTGN VISTAGEN THERAPEUTICS INC 0.5%

Value ($000) $533 Shares 150,000 Est. Cost $4.22 Unrealized -14.4%

ARVN ARVINAS INC 0.4%

Value ($000) $426 Shares 50,000 Est. Cost $7.58 Unrealized +43.9%

— MURAL ONCOLOGY PUB LTD CO 0.1%

Value ($000) $119 Shares 57,500 Est. Cost $2.07 Unrealized —

— THIRD HARMONIC BIO INC 0.0%

Value ($000) $0 Shares 3,824,417 Est. Cost $3.47 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ADVERUM BIOTECHNOLOGIES INC	3,057,526	$13,851	12.0%	$7.99	—	—	00773U207
ALMS	ALUMIS INC	1,210,415	$4,830	4.2%	$4.77	+46.4%	—	022307102
—	LAVA THERAPEUTICS NV	1,970,610	$3,074	2.7%	$1.27	—	—	N51517105
LONA	ATHIRA PHARMA INC	323,066	$1,337	1.2%	$3.92	+16.7%	—	04746L203
ASTC	ASTROTECH CORP	220,410	$1,080	0.9%	$11.26	-66.0%	—	046484309
VTGN	VISTAGEN THERAPEUTICS INC	150,000	$533	0.5%	$4.22	-14.4%	—	92840H400
ARVN	ARVINAS INC	50,000	$426	0.4%	$7.58	+43.9%	—	04335A105
—	MURAL ONCOLOGY PUB LTD CO	57,500	$119	0.1%	$2.07	—	—	G63365103
—	THIRD HARMONIC BIO INC	3,824,417	$0	0.0%	$3.47	—	—	88427A107

Decreased Positions (3)

CNTB CONNECT BIOPHARMA HLDGS LTD 1.0%

Value ($000) $1,153 (-39.8%) Shares 408,887 (-67.7%) Est. Cost $1.77 Unrealized +20.5%

IMA IMAGENEBIO INC 1.1%

Value ($000) $1,221 (-17.9%) Shares 177,026 (-3.0%) Est. Cost $13.25 Unrealized -44.1%

LSTA LISATA THERAPEUTICS INC 0.1%

Value ($000) $136 (-52.6%) Shares 73,348 (-33.2%) Est. Cost $2.58 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTB	CONNECT BIOPHARMA HLDGS LTD	408,887 (-67.7%)	$1,153 (-39.8%)	1.0%	$1.77	+20.5%	SHS	G23549101
IMA	IMAGENEBIO INC	177,026 (-3.0%)	$1,221 (-17.9%)	1.1%	$13.25	-44.1%	COM	45175G207
LSTA	LISATA THERAPEUTICS INC	73,348 (-33.2%)	$136 (-52.6%)	0.1%	$2.58	—	COM	128058302

Unchanged Positions (6)

ACRS ACLARIS THERAPEUTICS INC 37.1%

Value ($000) $42,893 Shares 14,250,000 Est. Cost $1.28 Unrealized +98.0%

AVIR ATEA PHARMACEUTICALS INC 23.1%

Value ($000) $26,739 Shares 7,490,000 Est. Cost $3.51 Unrealized -9.4%

TIL INSTIL BIO INC 6.1%

Value ($000) $7,102 Shares 645,600 Est. Cost $17.47 Unrealized -15.3%

KZR KEZAR LIFE SCIENCES INC 3.9%

Value ($000) $4,534 Shares 720,787 Est. Cost $5.37 Unrealized +8.7%

PMVP PMV PHARMACEUTICALS INC 5.7%

Value ($000) $6,615 Shares 5,292,000 Est. Cost $1.49 Unrealized -9.8%

ORMP ORAMED PHARMACEUTICALS INC 7.8%

Value ($000) $9,027 Shares 3,167,231 Est. Cost $2.32 Unrealized +3.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	ACLARIS THERAPEUTICS INC	14,250,000	$42,893	37.1%	$1.28	+98.0%	COM	00461U105
AVIR	ATEA PHARMACEUTICALS INC	7,490,000	$26,739	23.1%	$3.51	-9.4%	COM	04683R106
TIL	INSTIL BIO INC	645,600	$7,102	6.1%	$17.47	-15.3%	COM NEW	45783C200
KZR	KEZAR LIFE SCIENCES INC	720,787	$4,534	3.9%	$5.37	+8.7%	COM NEW	49372L209
PMVP	PMV PHARMACEUTICALS INC	5,292,000	$6,615	5.7%	$1.49	-9.8%	COM	69353Y103
ORMP	ORAMED PHARMACEUTICALS INC	3,167,231	$9,027	7.8%	$2.32	+3.8%	COM NEW	68403P203